Losers (% change)
Back to dashboard| Company Name | Symbol | Price | Prev. Close | Volume | Change | % Change |
|---|---|---|---|---|---|---|
| Viewbix Inc. - Common Stock | VBIX | 1.550 | 1.640 | 22,100 | -0.09 |
-5.49% |
| Cerence Inc. - Common Stock | CRNC | 12.08 | 12.78 | 1,151,868 | -0.70 |
-5.48% |
| XCHG Limited - ADS | XCH | 1.210 | 1.280 | 14,045 | -0.07 |
-5.47% |
| Lichen International Limited - Class A Ordinary Shares | LICN | 3.130 | 3.310 | 40,284 | -0.18 |
-5.44% |
| Zenta Group Company Limited - Ordinary Shares | ZGM | 2.700 | 2.855 | 8,332 | -0.15 |
-5.43% |
| Catheter Precision, Inc. Common Stock | VTAK | 2.790 | 2.950 | 49,108 | -0.16 |
-5.42% |
| Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A | BRKRP | 352.63 | 372.70 | 265 | -20.07 |
-5.39% |
| Amarin Corporation plc - American Depositary Shares | AMRN | 14.12 | 14.92 | 145,286 | -0.80 |
-5.36% |
| Bridger Aerospace Group Holdings, Inc. - Common Stock | BAER | 1.770 | 1.870 | 380,714 | -0.10 |
-5.35% |
| Metalpha Technology Holding Limited - Ordinary Shares | MATH | 2.860 | 3.020 | 84,568 | -0.16 |
-5.30% |
| Neumora Therapeutics, Inc. - Common Stock | NMRA | 2.075 | 2.190 | 746,606 | -0.11 |
-5.25% |
| Campbell Soup | CPB | 28.47 | 30.04 | 18,639,328 | -1.57 |
-5.23% |
| CMB.TECH NV Ordinary Shares | CMBT | 10.21 | 10.77 | 2,243,304 | -0.56 |
-5.20% |
| Pharvaris N.V. - Ordinary Shares | PHVS | 24.04 | 25.35 | 403,586 | -1.31 |
-5.17% |
| 4D Molecular Therapeutics, Inc. - Common Stock | FDMT | 10.51 | 11.08 | 816,012 | -0.57 |
-5.14% |
| Chemomab Therapeutics Ltd. - American Depositary Shares | CMMB | 2.600 | 2.740 | 160,563 | -0.14 |
-5.11% |
| Bally's Corporation Common Stock | BALY | 15.17 | 15.98 | 111,460 | -0.81 |
-5.07% |
| Janux Therapeutics, Inc. - Common Stock | JANX | 15.74 | 16.58 | 1,922,466 | -0.84 |
-5.07% |
| Ascendis Pharma A/S - American Depositary Shares | ASND | 196.63 | 207.12 | 894,673 | -10.49 |
-5.06% |
| MDJM LTD - Class A Ordinary Shares | UOKA | 3.111 | 3.275 | 39,625 | -0.16 |
-5.02% |
| Rapport Therapeutics, Inc. - Common Stock | RAPP | 28.65 | 30.16 | 423,553 | -1.51 |
-5.01% |
| Olema Pharmaceuticals, Inc. - Common Stock | OLMA | 26.58 | 27.98 | 2,458,526 | -1.40 |
-5.00% |
| BGM Group Ltd. - Class A Ordinary Shares | BGM | 6.300 | 6.630 | 6,492 | -0.33 |
-4.98% |
| Inhibrx Biosciences, Inc. - Common Stock | INBX | 88.89 | 93.51 | 143,333 | -4.62 |
-4.94% |
| Astera Labs, Inc. - Common Stock | ALAB | 167.08 | 175.74 | 5,018,918 | -8.66 |
-4.93% |
| Q/C Technologies, Inc. - Common Stock | QCLS | 6.560 | 6.900 | 11,987,128 | -0.34 |
-4.93% |
| Bon Natural Life Limited - Class A Ordinary Shares | BON | 1.750 | 1.840 | 16,813 | -0.09 |
-4.89% |
| Precigen, Inc. - Common Stock | PGEN | 3.510 | 3.690 | 2,355,194 | -0.18 |
-4.88% |
| Credo Technology Group Holding Ltd - Ordinary Shares | CRDO | 170.29 | 178.94 | 4,881,598 | -8.65 |
-4.83% |
| Monte Rosa Therapeutics, Inc. - Common Stock | GLUE | 16.99 | 17.85 | 776,429 | -0.86 |
-4.82% |
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.